Direct Effects Technology: A Non-Systemic Delivery of Cannabinoids and Other Neuro-Active Compounds

There is concern that cannabinoids may exert undesirable systemic side effects of psychosis, dependency, addiction; and, behavioral and cognitive problems. These are of particular concern with use in children with developing brains. In utilizing direct nerve connections from skin nerve endings to the central nervous system, systemic side effects and drug interactions are minimized or non-existent. Furthermore, therapeutic benefits are realized well within 15-20 minutes. The mechanism of action of Direct Effects Technology will be discussed and clinical data presented, using it with CBD in conditions such as autism, seizures, pain, PTSD, fibromyalgia, and mood disorders.

Go back